Duvelisib (R enantiomer)

CAS No. 1261590-48-0

Duvelisib (R enantiomer)( IPI-145 R enantiomer | INK1197 R enantiomer | Duvelisib R enantiomer )

Catalog No. M26184 CAS No. 1261590-48-0

Duvelisib R enantiomer is an enantiomer of Duvelisib with lower activity. Duvelisib is a PI3K inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 104 Get Quote
50MG 325 Get Quote
100MG 554 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Duvelisib (R enantiomer)
  • Note
    Research use only, not for human use.
  • Brief Description
    Duvelisib R enantiomer is an enantiomer of Duvelisib with lower activity. Duvelisib is a PI3K inhibitor.
  • Description
    Duvelisib R enantiomer is an enantiomer of Duvelisib with lower activity. Duvelisib is a PI3K inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    IPI-145 R enantiomer | INK1197 R enantiomer | Duvelisib R enantiomer
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1261590-48-0
  • Formula Weight
    416.87
  • Molecular Formula
    C22H17ClN6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (239.89 mM)
  • SMILES
    C[C@@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang G, Becker E, Mesa C. Optimization of 6-carboxy-X-rhodamine concentration for real-time polymerase chain reaction using molecular beacon chemistry. Can J Microbiol. 2007 Mar;53(3):391-7.
molnova catalog
related products
  • GNE-317

    GNE-317 (GNE317) is a potent, brain penepenetrant, dual PI3K/mTOR inhibitor having physicochemical properties predictive of low efflux by P-gp and BCRP.

  • RV-1729

    RV-1729 is a potent, selective PI3Kδ inhibitor with IC50 of 12 nM.

  • Leniolisib

    A novel potent and selective PI3Kδ inhibitor with biochemical IC50 of 11 nM; displays >20-fold, 40-fold, and 200-fold selectivity over PI3Kα, PI3Kβ, and PI3Kγ, respectively.